Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lamassu Bio Inc

Clinical trials sponsored by Lamassu Bio Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new pill shrink Hard-to-Treat tumors? Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Can a new pill shrink Hard-to-Treat tumors?

Disease control Recruiting now

This trial is testing an experimental drug called SA53-OS in people with advanced or metastatic solid tumors that have not responded to standard treatments. The drug works by blocking a protein called MDM2, which may help slow or stop tumor growth. The study has two parts: first,…

Phase 1/2 • Sponsor: Lamassu Bio Inc • Aim: Disease control

Last updated Sep 11, 2026 00:00 UTC